Response To: Cryoglobulinemic Vasculitis in the Era of Direct-Acting Antiviral Drug

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2016-210695
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy

Hepatology
MedicineHepatology
2017English

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

Frontiers in Medicine
Medicine
2019English

Cryoglobulinemic Vasculitis

2020English

Direct Acting Antiviral Regimens Usher in the Era of HCV Positive Donors in Lung Transplant

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era

Hepatology
MedicineHepatology
2018English

Barriers to Care for Chronic Hepatitis C in the Direct-Acting Antiviral Era: A Single-Centre Experience

BMJ Open Gastroenterology
Gastroenterology
2017English

Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report

BMC Nephrology
Nephrology
2017English

Systematic Review: Current Concepts and Challenges for the Direct-Acting Antiviral Era in Hepatitis C Cirrhosis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

A Rare Case of Cryoglobulinemic Vasculitis

Journal of Medical Science And clinical Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy